Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRA | P25101 | 9/20 | 0.70 |
| ▸ | EDNRB | P24530 | 9/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9053186 | 0.95 | EDNRA (0.78) | EDNRAEDNRB | |
| SCHEMBL9045370 | 0.91 | EDNRA (0.86) | EDNRAEDNRB | |
| SCHEMBL9046770 | 0.91 | EDNRA (0.75) | EDNRAEDNRB | |
| SCHEMBL9046504 | 0.89 | EDNRA (0.69) | EDNRAEDNRB | |
| SCHEMBL9044786 | 0.89 | EDNRA (0.89) | EDNRAEDNRB | |
| SCHEMBL9047331 | 0.88 | EDNRA (0.68) | EDNRAEDNRB | |
| SCHEMBL9046028 | 0.87 | EDNRA (0.81) | EDNRAEDNRB | |
| SCHEMBL9044642 | 0.85 | EDNRA (0.63) | EDNRAEDNRB | |
| SCHEMBL9044009 | 0.83 | EDNRA (0.86) | EDNRAEDNRB | |
| SCHEMBL9043808 | 0.82 | EDNRB (0.47) | EDNRAEDNRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0510526-B1 | Use of sulfonamides as drug and new sulfonamides | HOFFMANN LA ROCHE (CH) | 1996-12-04 | — | — | EP | claimed |
| US-5270313-A | Treatment of circulatory disorders | HOFFMANN-LA ROCHE INC. (US) | 1993-12-14 | — | — | US | claimed |
| EP-0510526-A1 | Use of sulfonamides as drug and new sulfonamides | F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) | 1992-10-28 | — | — | EP | claimed |
| EP-0510526-B1 | Use of sulfonamides as drug and new sulfonamides | HOFFMANN LA ROCHE (CH) | 1996-12-04 | — | — | EP | disclosed |
| US-5270313-A | Treatment of circulatory disorders | HOFFMANN-LA ROCHE INC. (US) | 1993-12-14 | — | — | US | disclosed |
| EP-0510526-A1 | Use of sulfonamides as drug and new sulfonamides | F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) | 1992-10-28 | — | — | EP | disclosed |